JK

Jyoti Kumar Singh

Active Director Designated Partner DIN 08623583
DIN 08623583 First appointment Nov 2019 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Jyoti Kumar Singh

Data last updated:

Jyoti Kumar Singh is a Designated Partner at Dimax Life Sciences Llp (since 2019). The company operates in Chemicals.

DIN 08623583
Primary Designation Designated Partner
Industry Chemicals
First Appointment 27 Nov 2019
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 Nov 20192019Active

Board colleagues of Jyoti Kumar Singh

NameDINCompanyDesignation
Amod Kumar Singh08623584Dimax Life Sciences LlpDesignated Partner
Amresh Kumar Jaggnath Singh08662118Dimax Life Sciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Dimax Life Sciences Llp
Premium access

Shareholding and investment profile for Jyoti Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti Kumar Singh

Jyoti Kumar Singh currently holds 1 directorship: Dimax Life Sciences Llp (Designated Partner, since 27 Nov 2019).

Jyoti Kumar Singh was first appointed on 27 Nov 2019 as Designated Partner at Dimax Life Sciences Llp.

The current boards of Jyoti Kumar Singh's companies include Amod Kumar Singh (Dimax Life Sciences Llp), Amresh Kumar Jaggnath Singh (Dimax Life Sciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available